Nanopath, a Cambridge, Mass.-based women’s health diagnostics company, raised $10 million in Series A funding, Per Axios. Norwest Venture Partners and the Medtech Convergence Fund co-led, and were joined by Gingerbread Capital and Green D Ventures.
Related Posts
Summus Global Hauls in $22M
Summus has now raised $50 million to expand its innovative specialty care platform.
March 2, 2022
OrthoPediatrics Raises $144M in IPO
The pre-funded warrants were purchased by Squadron Capital, the company’s largest investor, which beneficially owns shares with a value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act.
August 16, 2022